Johns Hopkins University School of Medicine researchers have discovered a dual regulatory mechanism safeguarding ...

In my work as a cancer researcher, I study the underlying mechanisms of how tumors develop and resist treatment. By ...

Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy.

CMRI researchers discovered that DNA repair pathways control how cancer cells die after radiotherapy. Blocking a key repair ...

Stanford Medicine researchers sifted through thousands of single nucleotide mutations in DNA to identify fewer than 400 that are functionally associated with inherited cancer risk.